Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy

Diabetic retinopathy (DR) is characterized by morphologic and metabolic alterations in endothelial cells (ECs) and pericytes (PCs) of the blood–retinal barrier (BRB). The loss of interendothelial junctions, increased vascular permeability, microaneurysms, and finally, EC detachment are the main feat...

Full description

Bibliographic Details
Main Authors: Gabriella Lupo, Aleksandra Agafonova, Alessia Cosentino, Giovanni Giurdanella, Giuliana Mannino, Debora Lo Furno, Ivana Roberta Romano, Rosario Giuffrida, Floriana D’Angeli, Carmelina Daniela Anfuso
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/2/913
_version_ 1797441709493190656
author Gabriella Lupo
Aleksandra Agafonova
Alessia Cosentino
Giovanni Giurdanella
Giuliana Mannino
Debora Lo Furno
Ivana Roberta Romano
Rosario Giuffrida
Floriana D’Angeli
Carmelina Daniela Anfuso
author_facet Gabriella Lupo
Aleksandra Agafonova
Alessia Cosentino
Giovanni Giurdanella
Giuliana Mannino
Debora Lo Furno
Ivana Roberta Romano
Rosario Giuffrida
Floriana D’Angeli
Carmelina Daniela Anfuso
author_sort Gabriella Lupo
collection DOAJ
description Diabetic retinopathy (DR) is characterized by morphologic and metabolic alterations in endothelial cells (ECs) and pericytes (PCs) of the blood–retinal barrier (BRB). The loss of interendothelial junctions, increased vascular permeability, microaneurysms, and finally, EC detachment are the main features of DR. In this scenario, a pivotal role is played by the extensive loss of PCs. Based on previous results, the aim of this study was to assess possible beneficial effects exerted by adipose mesenchymal stem cells (ASCs) and their pericyte-like differentiated phenotype (P-ASCs) on human retinal endothelial cells (HRECs) in high glucose conditions (25 mM glucose, HG). P-ASCs were more able to preserve BRB integrity than ASCs in terms of (a) increased transendothelial electrical resistance (TEER); (b) increased expression of adherens junction and tight junction proteins (VE-cadherin and ZO-1); (c) reduction in mRNA levels of inflammatory cytokines TNF-α, IL-1β, and MMP-9; (d) reduction in the angiogenic factor VEGF and in fibrotic TGF-β1. Moreover, P-ASCs counteracted the HG-induced activation of the pro-inflammatory phospho-ERK1/2/phospho-cPLA2/COX-2 pathway. Finally, crosstalk between HRECs and ASCs or P-ASCs based on the PDGF-B/PDGFR-β axis at the mRNA level is described herein. Thus, P-ASCs might be considered valuable candidates for therapeutic approaches aimed at countering BRB disruption in DR.
first_indexed 2024-03-09T12:28:03Z
format Article
id doaj.art-bae509e528da4295b2329016713d7a1b
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T12:28:03Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-bae509e528da4295b2329016713d7a1b2023-11-30T22:32:24ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-0124291310.3390/ijms24020913Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell TherapyGabriella Lupo0Aleksandra Agafonova1Alessia Cosentino2Giovanni Giurdanella3Giuliana Mannino4Debora Lo Furno5Ivana Roberta Romano6Rosario Giuffrida7Floriana D’Angeli8Carmelina Daniela Anfuso9Department of Biomedical and Biotechnological Sciences, Section of Medical Biochemistry, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, Section of Medical Biochemistry, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, Section of Medical Biochemistry, School of Medicine, University of Catania, 95123 Catania, ItalyFaculty of Medicine and Surgery, University of Enna “Kore”, 94100 Enna, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98122 Messina, ItalyDepartment of Biomedical and Biotechnological Sciences, Section of Physiology, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, Section of Physiology, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, Section of Physiology, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, Section of Physiology, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, Section of Medical Biochemistry, School of Medicine, University of Catania, 95123 Catania, ItalyDiabetic retinopathy (DR) is characterized by morphologic and metabolic alterations in endothelial cells (ECs) and pericytes (PCs) of the blood–retinal barrier (BRB). The loss of interendothelial junctions, increased vascular permeability, microaneurysms, and finally, EC detachment are the main features of DR. In this scenario, a pivotal role is played by the extensive loss of PCs. Based on previous results, the aim of this study was to assess possible beneficial effects exerted by adipose mesenchymal stem cells (ASCs) and their pericyte-like differentiated phenotype (P-ASCs) on human retinal endothelial cells (HRECs) in high glucose conditions (25 mM glucose, HG). P-ASCs were more able to preserve BRB integrity than ASCs in terms of (a) increased transendothelial electrical resistance (TEER); (b) increased expression of adherens junction and tight junction proteins (VE-cadherin and ZO-1); (c) reduction in mRNA levels of inflammatory cytokines TNF-α, IL-1β, and MMP-9; (d) reduction in the angiogenic factor VEGF and in fibrotic TGF-β1. Moreover, P-ASCs counteracted the HG-induced activation of the pro-inflammatory phospho-ERK1/2/phospho-cPLA2/COX-2 pathway. Finally, crosstalk between HRECs and ASCs or P-ASCs based on the PDGF-B/PDGFR-β axis at the mRNA level is described herein. Thus, P-ASCs might be considered valuable candidates for therapeutic approaches aimed at countering BRB disruption in DR.https://www.mdpi.com/1422-0067/24/2/913adipose mesenchymal stem cellspericyte-like differentiationretinal endothelial cellsblood–retinal barrierdiabetic retinopathyhyperglycemia
spellingShingle Gabriella Lupo
Aleksandra Agafonova
Alessia Cosentino
Giovanni Giurdanella
Giuliana Mannino
Debora Lo Furno
Ivana Roberta Romano
Rosario Giuffrida
Floriana D’Angeli
Carmelina Daniela Anfuso
Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy
International Journal of Molecular Sciences
adipose mesenchymal stem cells
pericyte-like differentiation
retinal endothelial cells
blood–retinal barrier
diabetic retinopathy
hyperglycemia
title Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy
title_full Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy
title_fullStr Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy
title_full_unstemmed Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy
title_short Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy
title_sort protective effects of human pericyte like adipose derived mesenchymal stem cells on human retinal endothelial cells in an in vitro model of diabetic retinopathy evidence for autologous cell therapy
topic adipose mesenchymal stem cells
pericyte-like differentiation
retinal endothelial cells
blood–retinal barrier
diabetic retinopathy
hyperglycemia
url https://www.mdpi.com/1422-0067/24/2/913
work_keys_str_mv AT gabriellalupo protectiveeffectsofhumanpericytelikeadiposederivedmesenchymalstemcellsonhumanretinalendothelialcellsinaninvitromodelofdiabeticretinopathyevidenceforautologouscelltherapy
AT aleksandraagafonova protectiveeffectsofhumanpericytelikeadiposederivedmesenchymalstemcellsonhumanretinalendothelialcellsinaninvitromodelofdiabeticretinopathyevidenceforautologouscelltherapy
AT alessiacosentino protectiveeffectsofhumanpericytelikeadiposederivedmesenchymalstemcellsonhumanretinalendothelialcellsinaninvitromodelofdiabeticretinopathyevidenceforautologouscelltherapy
AT giovannigiurdanella protectiveeffectsofhumanpericytelikeadiposederivedmesenchymalstemcellsonhumanretinalendothelialcellsinaninvitromodelofdiabeticretinopathyevidenceforautologouscelltherapy
AT giulianamannino protectiveeffectsofhumanpericytelikeadiposederivedmesenchymalstemcellsonhumanretinalendothelialcellsinaninvitromodelofdiabeticretinopathyevidenceforautologouscelltherapy
AT deboralofurno protectiveeffectsofhumanpericytelikeadiposederivedmesenchymalstemcellsonhumanretinalendothelialcellsinaninvitromodelofdiabeticretinopathyevidenceforautologouscelltherapy
AT ivanarobertaromano protectiveeffectsofhumanpericytelikeadiposederivedmesenchymalstemcellsonhumanretinalendothelialcellsinaninvitromodelofdiabeticretinopathyevidenceforautologouscelltherapy
AT rosariogiuffrida protectiveeffectsofhumanpericytelikeadiposederivedmesenchymalstemcellsonhumanretinalendothelialcellsinaninvitromodelofdiabeticretinopathyevidenceforautologouscelltherapy
AT florianadangeli protectiveeffectsofhumanpericytelikeadiposederivedmesenchymalstemcellsonhumanretinalendothelialcellsinaninvitromodelofdiabeticretinopathyevidenceforautologouscelltherapy
AT carmelinadanielaanfuso protectiveeffectsofhumanpericytelikeadiposederivedmesenchymalstemcellsonhumanretinalendothelialcellsinaninvitromodelofdiabeticretinopathyevidenceforautologouscelltherapy